Nazanin Majd, MD, PhD
@NazMajd
Followers
254
Following
206
Media
0
Statuses
100
Assistant Professor of Neuro-Oncology, MD Anderson Cancer Center. Tweets are my own.
Houston, TX
Joined March 2020
Exciting trial for patients with low grade gliomas! - We are targeting ERK for treatment of recurrent oligodendroglioma and NF1-associated low-grade glioma using ulixertinib in our surgical trial @MDAndersonNews #endcancer.
1
3
10
Do you have a newly diagnosed GBM patient, MGMT unmethylated with KIT or PDGFRA alterations? Phase 2 trial of avapritinib at MDA would provide an opportunity for upfront targeted therapy after chemoRT. Please reach out if you have trial candidates. @MDAndersonNews @NeuroNews01.
0
4
8
Do you have a newly diagnosed GBM, MGMT unmethylated patient who would benefit from more resection? We have a clinical trial opportunity for them. #endcancer @MDAndersonNews.
0
4
7
congratulations! very well deserved!.
The @MDAndersonNews Neuro-Oncology department is thrilled to announce the promotion of @ChetnaWathoo, M.D., to Associate Director, Research Planning & Development. Dr. Wathoo’s ongoing contributions through leadership, mentorship & innovation are vital in our goal to #EndCancer.
1
0
4
RT @DavidHongMD: DDR 🤴!!! The Taylor Swift of Oncology!!! The man the myth……………Tim Yap!! @MDAndersonNews #ASCO24
0
10
0
Our newly activated trial is specifically designed for patients with oligodendroglioma (CIC mutated) and NF1-associated gliomas Excited to announce this unique trial and accrue patients! #endcancer, @MDAndersonNews.
0
5
21
It was my honor and a privilege to present the highlights of CNS tumors at #ASCO2023! Specially, highlighting the historical study by Dr. Mellinghoff and colleagues. Thank you ASCO organizers! @MDAndersonNews.
nejm.org
Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas are malignant brain tumors that cause considerable disability and premature death. Vorasidenib, an oral brain-penetrant inhibitor of mutant IDH...
0
2
8
Great honor to see Dr. Tanner and Dr. Yung @DrAlfredYung at #ASCO23!.
Great to run into @NazMajd and @DrAlfredYung at #ASCO23 and chat about highlights from CNS presentations
0
1
7
Two of my favorite leaders committed to #endcancer! You are our source of inspiration! @DrAlfredYung , @MDAndersonNews.
0
0
6
RT @MDAndersonNews: To help reduce your cancer risk, aim for at least 150 minutes of moderate activity each week. Watch to see ideas for….
0
7
0
Enjoyed reading this article by my amazing colleague and friend, @AshleyAaroe. Our field is lucky to have you as our patients’ advocate! #neurology, #braintumor, @MDAndersonNews
neurologylive.com
Neuro-oncology fellow Ashley Aaroe recounts her experience at Neurology on the Hill, advocating for important changes in neurology health care.
1
1
12
Congratulations! Your proud sister and mentee! ❤️@majdzadehr.
After 15 years of intensive work, having +300 articles in PubMed, including prestigious journals: this is my favourite one: >3 years of work with a large group of researchers, community representatives, policymakers and managers. It has a video: see it.
0
0
3
Agree! This is a great resource for our patients! #BrainTumor #PatientCare.
We all know about @NCCN guidelines for clinical practice, but this massive patient information summary for glioma is news to me! Are other #neurologists and #neurooncs using this resource (or do you prefer your own).
0
0
2
Our updated Immunotherapy for Neuro-Oncology chapter is now available online! @MDAndersonNews Soecial thanks to @J_deGrootMD, Pushan Dasgupta, @ANaingMD, @HajjarJoud:
pubmed.ncbi.nlm.nih.gov
Immunotherapy has changed the landscape of treatment of many solid and hematological malignancies and is at the forefront of cancer breakthroughs. Several circumstances unique to the central nervous...
0
0
4
Congratulations! @HTawbi_MD and team! @MDAndersonNews Treatment advances in melanoma inspire all oncologists! #EndCancer.
On behalf of my colleagues, so excited to bring a new and safer immune checkpoint inhibitor combination to our patients with advanced melanoma, Relatlimab (anti-LAG3) with nivolumab improves PFS, minor increase in toxicity, new frontiers for #Immunotherapy
0
0
4
“Apart from hope’s fundamental role in healing,giving hope is one of the most beautiful acts of kindness.True,there is always the danger that the hope given may be unrealistic.But just as a bit of light dissipates alot of darkness,so can a bit of hope ameliorate a lot of despair”.
Because of the overwhelming interest in this special article by Dr. Daniel Drubach, who so eloquently describes his experiences as both #neurologist and patient with #dementia with Lewy bodies, we've made the article available to all at @AANMember
0
0
3